Shed
Moved to tryshed.com, where its own pages print compounded GLP-1s from $159 to $349 a month, and disagree on which applies.
- Medication
- compounded
- Commitment
- 3-month
- Insurance
- cash only
- Price checked
- 2026-09-22
Read from tryshed.com on 13 September 2026. shed.com, the address this card used, still lands on a domain broker's for-sale page; Shed now trades from tryshed.com, which carries the same "Lose 5% of your weight in 120 days or your money back" offer. Its weight-loss page prints "Compounded Semaglutide as low as $159/mo" and "Compounded Trizepatide starting as low as $239/mo" in its banner, and lower down lists "Compounded Semaglutide Injections GLP-1 receptor agonist Starting at $249/month" and "Compounded Tirzepatide Injections Dual-action GLP-1 and GIP receptor agonist Starting at $349/month". Its GLP-1 injections page reads "Starting at $199/month Medication and supplies included". None of these pages says which plan length the lower figures need, so the range here runs from the lowest to the highest figure Shed prints; ask which applies before paying.
What this page used to say
- 2026-09-13 — Whether Shed still sells. Was: The domain is for sale and there is nothing left to read a price from. Now: Trades from tryshed.com: semaglutide from $159 or $249 a month, tirzepatide from $239 or $349, as its own pages print them.
- 2026-09-11 — A pro quoting a price no longer published, withdrawn. Was: Flat $159/mo that does not increase as your dose escalates — unusual in compounded programs.
- 2026-09-05 — The summary line still quoted a price this page had withdrawn. Was: $159/mo compounded semaglutide, but you prepay the whole block up front. Now: The domain is for sale and there is nothing left to read a price from.
- 2026-08-30 — Removed the price and the verification date from the Shed page. Was: $159 a month, verified 10 June 2026. Now: No price. This page explains that the domain now resolves to a broker listing.
How this monthly figure is built
One price covering medication.
What does Shed actually charge?
halfrx records Shed at $159–$349 a month all-in, read from its own published page on 2026-09-22. What it costs once titrated is not published, which is a fact about the seller rather than a gap in the data. It commits you for 3 months. No FTC action, state action, BBB F grade or FDA warning letter is recorded against it. It scores 5.0 out of 10 on a published formula that is arithmetic over the facts on this page, not an editor's opinion. It is cash only: no insurance is billed, so the figure above is the whole of it. The medication is compounded rather than FDA approved: a copy made under the pharmacy-compounding exemption, which is a legal status and not a quality claim. The program includes clinical care and dispensing rather than a prescription alone. The page rests on 3 cited sources, at least one of them a manufacturer, regulator or journal. Molecule: semaglutide.
Tracked since 2026-06-10. Last corrected on 2026-09-11 — see what this page used to say, above.
No clinician has reviewed this page. Label and trial statements are quoted from the FDA label or the trial cited beside them. General guidance is marked as such, and every price carries the date it was verified. That is sourcing, not medical review. What we do and do not check · Who checked the price
What are the downsides of Shed?
How this score is built
- 1.5/2.5Cost — $349/mo at maintenance (top of the published range, since no ongoing price is published), scored against the $129–$699 spread of every verified price we track
- 0.0/2.5Medication — compounded medication, which the FDA does not review and which a court order can stop
- 0.8/1What they supply — strongest molecule offered: semaglutide
- 0.5/1Commitment — three-month contract
- 1.0/1Care around the prescription — coaching, titration support and insurance help included
- 1.2/2Conduct — −0.8: compounding legal risk −0.8
Who compounds it
Names no compounding pharmacy anywhere this site could read. Read 2026-09-10 across /. Every seller audited the same way →
The public record
Lawsuits, regulator actions, FDA warning letters and BBB grade, each with the document behind it. Is Shed legit? →
Sources
- [1] GLP-1 Telehealth Price Report 2026secondary
- [2] Compounded GLP-1 litigation overviewsecondary
- [3] Shed, weight-loss products pageprimary
Information only, not medical advice. Prices and terms change; the date above is when we last verified this one.
The registers and documents behind this page
The public record on Shed is the result of searching these. They are named so the search can be repeated.
- Warning letters, U.S. Food and Drug Administration — The register searched for every seller on this site. A letter found here is linked from the seller's page to the original.
- Cases and proceedings, Federal Trade Commission — The register searched for advertising and billing actions against a seller.
- Compounding and the FDA: questions and answers — What a compounded drug is, and what the FDA does and does not review before it is sold.
- Medications containing semaglutide marketed for type 2 diabetes or weight loss, FDA — The FDA's own notice on compounded semaglutide and what it has not evaluated.